Abstract
Background: Insulin increases glucose uptake in muscles and fat and inhibits hepatic glucose production, thus serving as the primary regulator of the blood glucose level. In type 2 diabetes, insufficient insulin release and suppressed insulin action [named insulin resistance] lead to increased glucose production in liver and decreased glucose uptake by muscles and fat tissues, resulting in elevated blood glucose concentration which is dangerous to human health. Therefore, the anti-diabetic therapies are aimed at inhibiting excess blood glucose.
Methods: A comparative analysis of two distinct glucose-lowering modes was used to develop a new feedback model for the purpose of identification of pharmacological targets in diabetes treatment.
Results: The current brief opinion proposes an original feedback control of glucose-lowering regulation and its models which allow comparing two distinct strategies of glucose level correction, i.e., one of them allows reducing the increased threshold of insulin resistance, whereas the other allows overcoming this threshold/barrier using exogenous insulin treatment. Also, this analytic research presents selected examples comparing the influence of the two analyzed strategies on the normalization of glucose metabolism, their therapeutic potential and side effects associated with additional weight gain. These models show the pathological mechanism by which exogenous insulin provokes formation of a «vicious cycle» by its side effects associated with additional weight gain.
Conclusion: The presented model and findings can contribute to the development of new anti-diabetic targets and drugs with minimal side effects.
Keywords: Chronic low-grade inflammation, diabetes, insulin resistance, metabolism, side effects, vicious cycle, weigh gain.
Current Pharmaceutical Design
Title:Glucose-lowering Strategies in Diabetes: Pharmacological Development of New Antidiabetic Drugs
Volume: 24 Issue: 9
Author(s): Polina Schwartsburd*
Affiliation:
- Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Institutskay ulitsa 3, Pushchino, Moscow Region, 142290,Russian Federation
Keywords: Chronic low-grade inflammation, diabetes, insulin resistance, metabolism, side effects, vicious cycle, weigh gain.
Abstract: Background: Insulin increases glucose uptake in muscles and fat and inhibits hepatic glucose production, thus serving as the primary regulator of the blood glucose level. In type 2 diabetes, insufficient insulin release and suppressed insulin action [named insulin resistance] lead to increased glucose production in liver and decreased glucose uptake by muscles and fat tissues, resulting in elevated blood glucose concentration which is dangerous to human health. Therefore, the anti-diabetic therapies are aimed at inhibiting excess blood glucose.
Methods: A comparative analysis of two distinct glucose-lowering modes was used to develop a new feedback model for the purpose of identification of pharmacological targets in diabetes treatment.
Results: The current brief opinion proposes an original feedback control of glucose-lowering regulation and its models which allow comparing two distinct strategies of glucose level correction, i.e., one of them allows reducing the increased threshold of insulin resistance, whereas the other allows overcoming this threshold/barrier using exogenous insulin treatment. Also, this analytic research presents selected examples comparing the influence of the two analyzed strategies on the normalization of glucose metabolism, their therapeutic potential and side effects associated with additional weight gain. These models show the pathological mechanism by which exogenous insulin provokes formation of a «vicious cycle» by its side effects associated with additional weight gain.
Conclusion: The presented model and findings can contribute to the development of new anti-diabetic targets and drugs with minimal side effects.
Export Options
About this article
Cite this article as:
Schwartsburd Polina *, Glucose-lowering Strategies in Diabetes: Pharmacological Development of New Antidiabetic Drugs, Current Pharmaceutical Design 2018; 24 (9) . https://dx.doi.org/10.2174/1381612824666171227222113
DOI https://dx.doi.org/10.2174/1381612824666171227222113 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Importance of Zinc in Cystic Fibrosis Patients
Current Pediatric Reviews Cardioprotection with opioids - Trusted old friends -Clinical Science -
Current Pharmaceutical Design Therapeutic Targeting of B Lymphocyte Stimulator (BLyS) in the Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets ULK1 Plays a Critical Role in AMPK-Mediated Myocardial Autophagy and Contractile Dysfunction following Acute Alcohol Challenge
Current Pharmaceutical Design Selenium Deficiency in Soils and Crops and its Impact on Animal and Human Health
Current Nutrition & Food Science A Discussion of Natural Rubber Latex Allergy with Special Reference to Children: Clinical Considerations
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Iron Supplementation Therapy in End-Stage Renal Disease Patients on Maintenance Hemodialysis
Cardiovascular & Hematological Disorders-Drug Targets The Prevalence of the Classical and Non-Classical Cardiovascular Risk Factors in Multiple Sclerosis Patients
CNS & Neurological Disorders - Drug Targets Targeting Cancer Stem Cells as a Therapeutic Approach in Liver Cancer
Current Gene Therapy Advancement in Microsphere Preparation Using Natural Polymers and Recent Patents
Recent Patents on Drug Delivery & Formulation Inappropriate Medication Use and Cost Comparison Analysis of Proton Pump Inhibitors: Evidence from an Indian Tertiary Care Facility
Current Drug Safety Editorial [Hot Topic: The Medicinal Chemistry of Glycosidase Inhibitors(Guest Editors: Seiichiro Ogawa and Hideya Yuasa)]
Current Topics in Medicinal Chemistry Ureas: Applications in Drug Design
Current Medicinal Chemistry Uremia, Atherothrombosis and Malnutrition: The Role of L-arginine- Nitric Oxide Pathway
Cardiovascular & Hematological Disorders-Drug Targets Meet Our Editorial Board Member
Endocrine, Metabolic & Immune Disorders - Drug Targets Green and Simple Synthesis of Silver Nanoparticles by Aqueous Extract of <i>Perovskia abrotanoides</i>: Characterization, Optimization and Antimicrobial Activity
Current Pharmaceutical Biotechnology Safety Issues of Vitamin D Supplementation
Anti-Cancer Agents in Medicinal Chemistry Non Alcoholic Fatty Liver: Epidemiology and Natural History
Reviews on Recent Clinical Trials Acknowledgement
Endocrine, Metabolic & Immune Disorders - Drug Targets Exercise Prescription for Post-Menopausal Women with Obesity
Current Women`s Health Reviews